Field-Induced SMM and Vis/NIR Luminescence on mononuclear lanthanide complexes with 9-Anthracenecarboxylate and 2,2':6,2'-Terpyridine.

Five new mononuclear lanthanide complexes are synthesized by adding the several lanthanide nitrate hexahydrate salts, which for lanthanide (Ln) are Eu, Tb, Dy, Er, and Yb, with 9-anthracenecarboxylic acid (9-Hanthc) and 2,20 :6,200-terpyridine (TPY) in mixed solution of methanol and dimethylformamide (DMF). The general formula is [Eu(9-anthc)3 (TPY)(DMF)]·H2O (1Eu) where Eu(III) is ennea-coordinated or [Ln(9-anthc)3 (TPY)(H2O)]·H2O·DMF (Ln = Tb (2Tb), Dy (3Dy), Er (4Er), and Yb (5Yb)) where Ln(III) is octa-coordinated. For compounds 3Dy, 4Er, and 5Yb, the dynamic ac magnetic study indicated field-induced single molecule magnet (SMM) behavior. The photoluminescence studies in the solid state of these complexes show the sensitization of 4f-4f transitions for 4Er and 5Yb in the NIR region

Magnetic and Luminescence Properties of 8-Coordinated Pyridyl Adducts of Samarium(III) Complexes Containing 4,4,4-Trifluoro-1-(naphthalen-2-yl)-1,3-butanedionate

A novel series of polypyridyl adducts, [Sm(ntfa)3(NN)] (2-4), with ntfa = 4,4,4-trifluoro-1-(naphthalen-2-yl)-1,3-butanedionate, NN = 2,2′-bipyridine (bipy), 4,4′-dimethyl-2,2′-bipyridine (4,4′-Me2bipy), and 5,5′-dimethyl-2,2′-bipyridine (5,5′-Me2bipy) were synthesized from the precursor complex [Sm(ntfa)3(MeOH)2] (1) and the corresponding pyridyl ligands. Single X-ray crystallography showed that the complexes displayed 8-coordinated geometry. The solid pyridyl adducts 2-4 exhibited emission of luminescence in the NIR and visible regions with close quantum yields (QY = 0.20-0.25%). The magnetic data of 1-4 showed larger values than those expected for magnetically noncoupled Sm(III) complexes in the 6H5/2 ground state, with no saturation on the applied high magnetic field static at a temperature of 2 K

Magnetic and Luminescence Properties of 8-Coordinate Holmium(III) Complexes Containing 4,4,4-Trifluoro-1-Phenyl and 1-(Naphthalen-2-yl)-1,3-Butanedionates.

A new series of mononuclear Ho3+ complexes derived from the β-diketonate anions: 4,4,4-trifluoro-1-phenyl-1,3-butanedioneate (btfa−) and 4,4,4-trifuoro-1-(naphthalen-2-yl)-1,3-butanedionate (ntfa−) have been synthesized, [Ho(btfa)3(H2O)2] (1a), [Ho(ntfa)3(MeOH)2] (1b), (1), [Ho(btfa)3(phen)] (2), [Ho(btfa)3(bipy)] (3), [Ho(btfa)3(di-tbubipy)] (4), [Ho(ntfa)3(Me2bipy)] (5), and [Ho(ntfa)3(bipy)] (6), where phen is 1,10-phenantroline, bipy is 2,2′-bipyridyl, di-tbubipy is 4,4′-di-tert-butyl-2,2′-bipyridyl, and Me2bipy is 4,4′-dimethyl-2,2′-bipyridyl. These compounds have been characterized by elemental microanalysis and infrared spectroscopy as well as single-crystal X-ray difraction for 2-6. The central Ho3+ ions in these compounds display coordination number 8. The luminescence-emission properties of the pyridyl adducts 2-6 display a strong characteristic band in the visible region at 661 nm and a series of bands in the NIR region (excitation wavelengths (λex) of 367 nm for 2-4 and 380 nm for 5 and 6). The magnetic properties of the complexes revealed magnetically uncoupled Ho3+ compounds with no field-induced, single-molecule magnet (SMMs)

Diverse coordination numbers and geometries in pyridyl adducts of lanthanide(III) complexes based on beta-diketonate

t: Ten mononuclear rare earth complexes of formula [La(btfa)3 (H2O)2 ] (1), [La(btfa)3 (4,40 - Mt2bipy)] (2), [La(btfa)3 (4,40 -Me2bipy)2 ] (3), [La(btfa)3 (5,50 -Me2bipy)2 ] (4), [La(btfa)3 (terpy)] (5), [La(btfa)3 (phen)(EtOH)] (6), [La(btfa)3 (4,40 -Me2bipy)(EtOH)] (7), [La(btfa)3 (2-benzpy)(MeOH)] (8), [Tb(btfa)3 (4,40 -Me2bipy)] (9) and (Hpy)[Eu(btfa)4 ] (10), where btfa = 4,4,4-trifuoro-1-phenylbutane1,3-dionato anion, 4,40 -Mt2bipy = 4,40 -dimethoxy-2,20 -bipyridine, 4,40 -Me2bipy = 4,40 -dimethyl2,20 -bipyridine, 5,50 -Me2bipy = 5,50 -dimethyl-2,20 -bipyridine, terpy = 2,20 :60 ,20 -terpyridine, phen = 1,10-phenathroline, 2-benzpy = 2-(2-pyridyl)benzimidazole, Hpy = pyridiniumH+ cation) have been synthesized and structurally characterized. The complexes display coordination numbers (CN) eight for 1, 2, 9, 10, nine for 5, 6, 7, 8 and ten for 3 and 4. The solid-state luminescence spectra of Tb-9 and Eu-10 complexes showed the same characteristic bands predicted from the Tb(III) and Eu(III) ions. The Overall Quantum Yield measured (φTOT) at the excitation wavelength of 371 nm for both compounds yielded 1.04% for 9 and up to 34.56% for 10 years

Insights into the Spin Dynamics of Mononuclear Cerium(III) Single-Molecule Magnets

Four novel CeIII mononuclear complexes of formulas [Ce(ntfa)3(MeOH)2] (1), [Ce(ntfa)3(5,5′-Me2bipy)] (2), [Ce(ntfa)3(terpy)] (3), and [Ce(ntfa)3(bipy)2] (4), where ntfa = 4,4,4-trifluoro-1-(naphthalen-2-yl)butane-1,3-dionato, 5,5′-Me2bipy = 5,5′-dimethyl-2,2′-dipyridyl, terpy = 2,2′:6′,2″-terpyridine, and bipy = 2,2′-bipyridine, have been synthesized and structurally characterized with CeIII displaying coordination numbers of 8, 8, 9, and 10, respectively. Magnetic measurements indicate that all the complexes show a field-induced single-ion magnet behavior under a small applied dc field. The magnetic analysis shows the relevance of the different spin relaxation mechanisms in the magnetic relaxation of the CeIII compounds, with special emphasis on the local-mode process. Multiconfigurational calculations were also performed to get more information on the axiality of the compounds

Síntesi i caracterització de compostos polinuclears derivats de lligands fosfonats amb cations paramagnètics 3d. Estudi magnètic

L’inici de la utilització d’àcids R-fosfònics en la síntesi de compostos de metalls de transició està relacionat amb el descobriment als anys 40 del segle passat dels àcids aminofosfònics en organismes vius, com l’àcid 2-aminoetilfosfònic en anèmones de mar. Posteriorment, es va reconèixer el potencial dels R-fosfonats com a mimètics dels fosfats naturals. La substitució de l’oxigen que connecta la part orgànica dels fosfats per un carboni als R-fosfonats dóna lloc a que aquests últims siguin químicament més estables i resistents al trencament per hidròlisi enzimàtica. La forta relació estructural amb compostos naturals, juntament amb l’alta estabilitat i baixa toxicitat, fa que els R-fosfonats puguin actuar com a antimetabòlits i els permet competir pels centres actius d’enzims o receptors cel•lulars. Els diversos usos dels R-fosfonats en sistemes biològics es deuen a les seves característiques combinades: geometria tetraèdrica, habilitat per a formar interaccions electrostàtiques i ponts d’hidrogen, i a la seva capacitat per enllaçar-se a diversos ions metàl•lics. La recent expansió en la química de coordinació d’organofosfonats metàl•lics ha estat estimulada per les seves aplicacions en absorció, catàlisi i suports catalítics, bescanvi d’ions, sensors i medicaments (en els últims 10 anys s’han descobert nous agents terapèutics per diverses malalties tals com la diabetis, asma, inflamació, insuficiència cardíaca, càncer, malària i VIH). Els tipus estructurals trobats als derivats metàl•lics dels organofosfonats són molt variats i estan representats per complexos de coordinació mononuclears, clústers moleculars, materials monodimensionals, fases bidimensionals, i xarxes tridimensionals. Alguns metal•loorganofosfonats han ajudat a entendre fenòmens magnètics tals com l’spin canting, l’anisotropia, dinàmiques de relaxació i transicions magnètiques induïdes per camp. Per tal d’obtenir compostos moleculars derivats d’organofosfonats es segueixen diverses estratègies: el mètode solvotermal, el mètode de l’eliminació de l’alquil, el mètode de l’àcid organofosfònic voluminós, el mètode del lligand auxiliar o co-lligand i el mètode d’expansió del clúster. Per al desenvolument d’aquesta tesi s’han seguit tres d’aquests mètodes. El primer mètode consisteix en la utilització d’un lligand organofosfonat voluminós. Amb aquesta finalitat s’han utilitzat: l’àcid metilfosfònic, l’àcid etilfosfònic, l’àcid fenilfosfònic, l’àcid fosfonoacètic, l’àcid 3-fosfonopropiònic i l’àcid tert-butilfosfònic. Amb aquesta familia de lligands s’han obtingut diverses families de compostos polinuclears de coure i manganès. El segon mètode consisteix en utilitzar lligands auxiliars per tal d’ocupar algunes de les posicions de coordinació del metall i evitar la seva polimerització. Els lligands auxiliars utilitzats són de diferents tipus: un aminoalcohol (1,3-bis(dimetilamino)-2-propanol), cetona (di(2-piridil)cetona), cetoxima (di-2-piridiletoxima) i de tipus heterocíclics N-donadors (derivats de la 2,2’-bipiridina i de la 1,10-fenantrolina). El tercer mètode consisteix en partir d’un complex precursor i fer-lo reaccionar amb el lligands desitjats per tal d’augmentar la seva nuclearitat. Per tal de seguir aquesta estratègia es van sintetitzar un complexes trinuclears de valència mixta de MnII/MnIII, aquests complexes posteriorment es fan reaccionar amb àcids fosfònics o fosfínics i s’obtenen complexes hexanuclears de MnIII. Una vegada obtinguts els compostos es procedeix a la seva caracterització: resolució estructural a partir de difracció de raigs X sobre monocristall, espectre d’infraroig, anàlisi elemental i mesures magnètiques. Una vegada es tenen totes aquestes dades es procedeix a fer relacions magneto-estructurals.In the past decades there has been an increasing interest in the study of phosphonic acids derivatives as stable mimetics of natural phosphates and substrates in the study of biochemical processes. In particular, aminophosphonic acids derivatives are isosteres of the corresponding amino acids and exhibit a variety of important biological properties applications, in quite different fields such as agriculture and human health, have been reported, such as: enzyme inhibitors; antifungal agents; herbicides, plant growth regulators and pesticides; immune system activators; neuroactive compounds; antitumour compounds; antiviral compounds; antibacterial compounds. The diferent uses of R-phosphonates in biologic systems is due to the combination of their four characteristics: tetrahedral geometry, hability to form electrostatic interactions and hidrogen bonds, and their capability to bind to diferent metallic ions. To obtain molecular compounds derived from organophosphonates we can follow diferent methods: the solvothermal/hidrothermal method, the alkyl elimination method, the bulky phosphonic acid method, the ancillary ligand or co-ligand method and the cluster expansion method. In the development of this thesis we have followed three of these methods. The first method is to use a bulky phosphonic acid, we achieved this by using the following ligands: methylphosphonic acid, ethylphosphonic acid, phenylphosphonic acid, phosphonoacetic acid, 3-phosphonopropionic acid and tert-butylphosphonic acid. The secod method was to use ancillary ligands, we used several derivatives of the 2,2’-bipyridyne and 1,10-phenanthroline, oximes, ketoximes and aminoalcohols. And the third method was the cluster expansion, for this we synthesed an oxo-centered trimetallic mixed valence cage MnIII2MnII. All these strategies gave place to several families of copper and manganese molecular complexes

Calibrating the coordination chemistry tool chest: metrics of bi- and tridentate ligands

Bi- and multidentate ligands form part of the tools commonly used for designing coordination and supramolecular complexes with desired stereochemistries. Parameters and concepts usually employed include the normalized bite of bidentate ligands, their cis- or trans-coordinating ability, their rigidity or flexibility, or the duality of some ligands that can act in chelating or dinucleating modes. In this contribution we present a structural database study of over one hundred bi- and tridentate ligands that allows us to parametrize their coordinating properties and discuss the relevance of such parameters for the choice of coordination polyhedron or coordination sites

L’électroencéphalographie : un bio-marqueur pour le développement clinique de nouveaux traitements pharmacologiques de la maladie d’Alzheimer

Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest effect on cognitive functioning. In addition, the clinical development of new and more effective compounds is hampered by the lack of predictive criteria to judge their early clinical efficacy.In this context, electroencephalography (EEG) could be a sufficiently sensitive biomarker to identify in an early stage (i.e. Phase I) the therapeutic potential of a new molecule on cognitive functioning. In addition, the difficulty to detect subtle improvements in cognitive performance in Phase I (i.e. in healthy subjects) could be overcome by the development of experimental paradigms such as sleep deprivation (SD), to induce cognitive deficits, still reversible in healthy subjects.EEG and EEG coupled with sleep deprivation (SD) would be innovative and relevant strategies to determine and predict the clinical effectiveness of a molecule in Phase I.In this work, we try to determine the relevance of such strategies by identifying, in healthy subjects, EEG markers of cognitive functioning related to (1) either the taking of a cognitive drug, (2) or the induction of a reversible cognitive decline, (3) or concomitant effects of the two parameters. In order to do that, two studies were performed.In a first study, the effect of donepezil on cortical electrical activity was studied in 30 young, healthy adult volunteers. These volunteers were treated with donepezil (5 mg/day orally) (vs. placebo) for 15 days following a double-blind, randomized, cross-over trial.At the end of the treatment period, an EEG (58 electrodes) was performed during two attentional tasks (auditory and visual). Event-related potentials (ERP), the inter-trial coherence (ITC) and the event-related spectral perturbation (ERSP) were then calculated.In a second study, the effect of SD was studied in 36 young, healthy adult volunteers. In addition, the effect of a cognitive drug (involving high alertness), the modafinil was also studied on this SD._x000D_Following a SD of 24 h, the participants were administered a dose of modafinil (200 mg in a single dose) (vs. placebo) in a double-blind, randomized, cross-over trial. An EEG (25 electrodes) was performed in a hearing attentional task (identical to that of Study 1) before and after the PS. The ERP, ITC and ERSP were then calculated.Through these two studies, we have found, at the group level, cognitive EEG markers related either to the induction of cognitive decline (SD) or pharmacological intervention targeting cholinergic system (donepezil) or several neurotransmitters (modafinil). All these markers would concern the modulation of cortical activity in the ventral frontoparietal network, known to regulate attentional and executive processes. We also confirmed that the network is underlying by δ/θ and α oscillatory activities. The cognitive efficiency would reflect the integrity of the network.We conclude that EEG is a sufficiently sensitive tool to detect subtle changes in neurocognitive processes of young, healthy adult volunteers, following the administration of a treatment of AD and more generally following the administration of a drug having an effect on cognition when cognitive decline is caused (SD).EEG and EEG coupled with SD could constitute additional tools to the current cognitive assessment for predicting the efficacy of new drug candidates for AD before initiation Phases II/III clinical trials. However, the present works needs to be replicated so that the EEG markers described here can be validated so as to be used in drug trials.Les traitements pharmacologiques symptomatiques de la maladie d’Alzheimer (MA) actuellement commercialisés ont un effet modeste sur le fonctionnement cognitif. De plus, le développement clinique de nouveaux composés plus efficaces est freiné par l’absence de critères prédictifs pour juger précocement de leur efficacité clinique.Dans ce contexte, l’électroencéphalographie (EEG) pourrait constituer un bio-marqueur suffisamment sensible pour identifier précocement (Phase I) le potentiel thérapeutique d’une nouvelle molécule sur le fonctionnement cognitif. De plus, la difficulté pour détecter des améliorations subtiles dans les performances cognitives en Phase I (i.e. chez des sujets sains) pourrait être palliée par le développement de paradigmes expérimentaux, tels que la privation de sommeil (PS), visant à induire des déficits cognitifs réversibles chez le sujet sain.Ainsi, l’EEG et l’EEG couplée à la privation de sommeil (PS) seraient des stratégies innovantes et pertinentes pour juger et prédire l’efficacité clinique d’une molécule en Phase I.Dans ce travail, nous tentons de juger de la pertinence de telles stratégies en identifiant, chez des sujets sains, des marqueurs EEG du fonctionnement cognitif liés soit (1) à la prise d’un médicament ayant un effet sur la cognition, (2) soit à l’induction d’un déclin cognitif réversible, (3) soit à l’effet concomitant des deux paramètres. Pour y parvenir, deux études ont été réalisées.Dans une première étude, l’effet du donepezil sur l’activité électrique corticale a été étudié chez 30 volontaires adultes, jeunes et sains. Ces volontaires ont été traités par donepezil (5 mg/jour per os) (vs. placebo) pendant 15 jours suivant une procédure en double aveugle, randomisée et en cross-over. _x000D_A la fin de la période de traitement, un EEG (58 voies) a été réalisé au cours de deux tâches attentionnelles (auditive et visuelle). Les potentiels évoqués cognitifs (PEC), la cohérence de phase inter-essais (ITC) et la perturbation spectrale liée à l’événement (ERSP) ont ensuite été calculés.Dans une deuxième étude, l’effet d’une PS a été étudié chez 36 volontaires adultes, jeunes et sains. De plus, l’effet d’un médicament ayant un effet bien connu sur la cognition (en particulier sur la vigilance), le modafinil, a également été étudié sur cette PS.Suite à une PS de 24 h, les participants se sont vus administrés une dose de modafinil (200 mg en prise unique) (vs. placebo) suivant une procédure en double aveugle, randomisée et en cross-over. Un EEG (25 voies) a été réalisé au cours d’une tâche attentionnelle auditive (identique à celle de l’étude I) avant et après la PS. Les PEC, l’ITC et l’ERSP ont ensuite été calculés.Grâce à ces deux études, nous avons identifié, à l’échelle de groupe, des marqueurs EEG de la cognition liés soit à l’induction d’un déclin cognitif (induit par une PS), soit à l’intervention pharmacologique ciblant le système cholinergique (donepezil) ou différents neurotransmetteurs (modafinil). L’ensemble de ces marqueurs porterait sur la modulation de l’activité corticale au sein du réseau fronto-pariétal ventral, connu pour régir les processus attentionnels et exécutifs. Nous avons également confirmé que ce réseau serait sous-tendu par des activités oscillatoires δ/θ et α. L’efficience cognitive serait le reflet de l’intégrité de ce réseau.Nous avons conclu que l’EEG est un outil suffisamment sensible pour détecter des changements subtils dans les processus neurocognitifs de participants adultes, jeunes et sains suivant l’administration d’un traitement de la MA et de manière plus générale suivant l’administration d’un médicament ayant un effet sur la cognition lorsqu’un déclin cognitif est provoqué (PS).Sous réserve de réplication des résultats et d’analyses complémentaires, l’EEG ainsi que l’EEG couplée à la PS pourraient constituer des outils additionnels à l’évaluation cognitive pour prédire l’efficacité de nouveaux candidat médicaments de la MA

Dinuclear Ln III Complexes with 9-Anthracenecarboxylate Showing Field-Induced SMM and Visible/NIR Luminescence

International audienc

Field-Induced SMM and Vis/NIR Luminescence on Mononuclear Lanthanide Complexes with 9-Anthracenecarboxylate and 2,2′:6,2″-Terpyridine

Five new mononuclear lanthanide complexes are synthesized by adding the several lanthanide nitrate hexahydrate salts, which for lanthanide (Ln) are Eu, Tb, Dy, Er, and Yb, with 9-anthracenecarboxylic acid (9-Hanthc) and 2,2′:6,2″-terpyridine (TPY) in mixed solution of methanol and dimethylformamide (DMF). The general formula is [Eu(9-anthc)3(TPY)(DMF)]·H2O (1Eu) where Eu(III) is ennea-coordinated or [Ln(9-anthc)3(TPY)(H2O)]·H2O·DMF (Ln = Tb (2Tb), Dy (3Dy), Er (4Er), and Yb (5Yb)) where Ln(III) is octa-coordinated. For compounds 3Dy, 4Er, and 5Yb, the dynamic ac magnetic study indicated field-induced single molecule magnet (SMM) behavior. The photoluminescence studies in the solid state of these complexes show the sensitization of 4f-4f transitions for 4Er and 5Yb in the NIR region